StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > From IR last week

<< Previous

Bullboard Posts

Next >>

Comment by Nailbiter2on Sep 26, 2024 9:51pm

36 Views

Post# 36243399

RE:RE:RE:RE:RE:RE:RE:From IR last week

Thought you had me on mute buddy.
Lyin' bugga.
In your head for life I guess.

IainCaimbeul wrote: Nope, wrong as usual.

Nailbiter2 wrote: Iain is going to have this post removed for bullying

LithLover wrote: It makes no sense other than Riggs they don't hold a lot of shares let it stay delisted and milk the company or sell it and move on. The only reason to get back on an exchange is if there is some big news otherwise it's just repeat this insanity.